In a multivariate study that included 168 patients who underwent radical prostatectomy for prostate cancer, HMGB1 expression was associated with pathological stage of prostate cancer, Gleason score, and pathological stage, and could also be an independent prognostic factor for biochemical recurrence-free survival after radical prostatectomy (93). This evidence concerns the gene HMGB1 and prostate carcinoma.